Latest

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Tuesday, 05 May 2026 10:16AM

 MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis s...

See More
Introducing Jumio Watch: Because Identity Risk Doesn’t End at Onboarding

Tuesday, 05 May 2026 9:34AM

Introducing Jumio Watch: Because Identity Risk Doesn’t End at OnboardingEarly studies show 25%...

See More

Other Press Release

MREM Banner
MREM Banner

Another project by BERNAMA Media Relations and Event Management (MREM)

Click here to add free PRESS RELEASES to your website